Skip to main
BLND

Blend Labs (BLND) Stock Forecast & Price Target

Blend Labs (BLND) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Blend Labs Inc. demonstrates a strong positive outlook due to its robust pipeline, which has increased by 18% year-over-year, capturing over 4% of the 2024 HMDA market share. The introduction of the Rapid Refi product is expected to enhance economic value per loan while overall profitability continues to expand, even in a low-volume mortgage environment. Additionally, recent quarterly results highlight significant growth in the consumer banking suite, with a 43% revenue increase, underscoring Blend Labs' ability to gain market share and expand its total addressable market.

Bears say

Blend Labs Inc. is experiencing a significant and unexpected decline in mortgage volumes, which has raised concerns regarding its financial outlook. The company's mortgage economic value per funded loan has also decreased from $93 to $88, reflecting adverse effects from a recent transition to a partnership model for certain business segments. With an anticipated continuation of mortgage volume slowdowns and potential interest rate hikes in the coming years, Blend's ability to achieve its financial targets appears increasingly uncertain, negatively impacting its overall stock outlook.

Blend Labs (BLND) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Blend Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Blend Labs (BLND) Forecast

Analysts have given Blend Labs (BLND) a Buy based on their latest research and market trends.

According to 7 analysts, Blend Labs (BLND) has a Buy consensus rating as of Feb 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Blend Labs (BLND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.